0001144204-18-052404.txt : 20181003 0001144204-18-052404.hdr.sgml : 20181003 20181003190054 ACCESSION NUMBER: 0001144204-18-052404 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180508 FILED AS OF DATE: 20181003 DATE AS OF CHANGE: 20181003 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Ford David A CENTRAL INDEX KEY: 0001705295 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35668 FILM NUMBER: 181106560 MAIL ADDRESS: STREET 1: 7 OAKRIDGE ROAD CITY: ANNANDALE STATE: NJ ZIP: 08801 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: INTERCEPT PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0001270073 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 223868459 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 10 HUDSON YARDS, 37TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10001 BUSINESS PHONE: 646-747-1000 MAIL ADDRESS: STREET 1: 10 HUDSON YARDS, 37TH FLOOR CITY: New York STATE: NY ZIP: 10001 FORMER COMPANY: FORMER CONFORMED NAME: INTERCEPT PHARMACEUTICALS INC DATE OF NAME CHANGE: 20031113 4 1 tv503772_4.xml OWNERSHIP DOCUMENT X0306 4 2018-05-08 0 0001270073 INTERCEPT PHARMACEUTICALS, INC. ICPT 0001705295 Ford David A C/O INTERCEPT PHARMACEUTICALS, INC. 10 HUDSON YARDS, FLOOR 37 NEW YORK NY 10001 0 1 0 0 Chief Human Resources Officer Common Stock 2018-05-08 4 F 0 510 70.15 D 9662 D Common Stock 2018-08-08 4 F 0 128 116.84 D 9662 D Represents shares of common stock withheld to satisfy taxes associated with the vesting of restricted stock. In each case, the amount of securities beneficially owned following the reported transactions is provided as of the date of this Form 4. /s/ Mark Pruzanski, as attorney-in-fact 2018-10-03